Holen Sie sich die Stockscreener-App
234.30
1.34%
3.2119
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt WST?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$231.09
Offen:
$234.58
24-Stunden-Volumen:
234.34K
Relative Volume:
0.26
Marktkapitalisierung:
$16.85B
Einnahmen:
$3.07B
Nettoeinkommen (Verlust:
$493.70M
KGV:
34.49
EPS:
6.7935
Netto-Cashflow:
$468.90M
1W Leistung:
-4.75%
1M Leistung:
-6.51%
6M Leistung:
-7.62%
1J Leistung:
+4.68%
1-Tages-Spanne:
$231.43
$237.20
1-Wochen-Bereich:
$228.40
$249.16
52-Wochen-Spanne:
$187.43
$322.34
West Pharmaceutical Services Inc Stock (WST) Company Profile
Firmenname
West Pharmaceutical Services Inc
Sektor
Telefon
(610) 594-2900
Adresse
530 HERMAN O. WEST DRIVE, EXTON, PA
Compare WST vs ISRG, BDX, ALC, RMD, MDLN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
233.94 | 16.64B | 3.07B | 493.70M | 468.90M | 6.7935 |
|
ISRG
Intuitive Surgical Inc
|
472.18 | 170.20B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
160.62 | 45.41B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
77.08 | 38.26B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
RMD
Resmed Inc
|
231.80 | 33.86B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
40.92 | 33.33B | 28.43B | 1.16B | 1.26B | 1.4457 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-02 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2025-09-15 | Eingeleitet | Rothschild & Co Redburn | Buy |
| 2025-06-24 | Eingeleitet | Barclays | Equal Weight |
| 2025-03-18 | Eingeleitet | Evercore ISI | Outperform |
| 2025-02-14 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2025-01-08 | Eingeleitet | Citigroup | Buy |
| 2024-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-12-12 | Hochstufung | UBS | Neutral → Buy |
| 2024-02-07 | Hochstufung | Jefferies | Hold → Buy |
| 2023-06-16 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-04-11 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Hold |
| 2022-11-30 | Eingeleitet | UBS | Neutral |
| 2022-10-28 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | Eingeleitet | Stephens | Equal-Weight |
| 2020-07-21 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-04-24 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | Herabstufung | Jefferies | Buy → Hold |
| 2019-04-23 | Eingeleitet | William Blair | Outperform |
| 2018-04-25 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | Eingeleitet | Goldman | Neutral |
| 2017-10-17 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | Eingeleitet | Stephens | Equal-Weight |
| 2017-09-15 | Hochstufung | Jefferies | Hold → Buy |
| 2016-10-28 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | Eingeleitet | Wells Fargo | Outperform |
| 2010-05-14 | Bestätigt | UBS | Neutral |
| 2010-02-23 | Eingeleitet | Jefferies & Co | Buy |
| 2008-12-19 | Eingeleitet | UBS | Neutral |
Alle ansehen
West Pharmaceutical Services Inc Aktie (WST) Neueste Nachrichten
West Pharmaceutical declares dividend, authorizes $1B buyback - MSN
West Pharmaceutical CEO Eric Green to retire in second half 2026 - Investing.com Nigeria
John Chevedden Submits Shareholder Proposal to West Pharmaceutical - marketscreener.com
West Pharmaceutical Receives Shareholder Proposal from John Chevedden - marketscreener.com
Swiss National Bank Trims Stock Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
Schroder Investment Management Group Acquires 23,474 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
Korea Investment CORP Increases Stock Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
Compelling Arguments for Including West Pharmaceutical Shares in Your Investment Portfolio Today - Bitget
Reasons to Add West Pharmaceutical Stock to Your Portfolio Right Now - Yahoo Finance
West Pharmaceutical Services Hits Day Low at $228.40 Amid Price Pressure - Markets Mojo
Winners And Losers Of Q4: West Pharmaceutical Services (NYSE:WST) Vs The Rest Of The Drug Development Inputs & Services Stocks - Yahoo Finance
West Pharmaceutical Services CEO to retire - Pennsylvania Business Report -
Are Wall Street analysts bullish on West Pharmaceutical Services stock? - MSN
Barclays PLC Sells 59,572 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharma CEO Eric Green to retire after 11 years at the helm - Reuters
West Pharmaceutical Services Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
3 Reasons to Sell WST and 1 Stock to Buy Instead - Finviz
West Pharmaceutical Services launches West Synchrony S1 prefillable syringe system - Traders Union
West Pharmaceutical Services Inc (WST) Trading Down 4.48% on Mar 10 - GuruFocus
West Pharmaceutical Services (NYSE:WST) Shares Gap DownShould You Sell? - MarketBeat
West Pharmaceutical (WST) slides as investors digest CEO retirement plan and conference commentary - Quiver Quantitative
West Pharmaceutical at Barclays Conference: Strategic Shifts and Growth Projections - Investing.com
West Pharmaceutical (WST) Announces CEO Eric Green's Upcoming Re - GuruFocus
West Pharmaceutical (WST) CEO to Retire, Leadership Transition P - GuruFocus
West Pharmaceutical CEO Eric Green to retire in second half 2026 By Investing.com - Investing.com South Africa
West Pharmaceutical Services (WST) Announces CEO Retirement Plans - GuruFocus
West Pharmaceutical Services, Inc. Announces Eric M. Green Plans to Retire as Chief Executive Officer - marketscreener.com
After doubling sales and 350% return, West Pharma chief plans exit - Stock Titan
West Pharmaceutical Services to Present at Two Healthcare Conferences - MyChesCo
LGT Group Foundation Sells 14,341 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
Pharmaceutical Packaging Market to Exceed $219B by 2031 as Sustainability & Injectable Drug Packaging Reshape Industry Dynamics, Says Mordor Intelligence - GlobeNewswire Inc.
Blair William & Co. IL Has $16.79 Million Holdings in West Pharmaceutical Services, Inc. $WST - MarketBeat
Female expert achievements celebrated with new blog articles, West Pharmaceutical Services asserts - Traders Union
West Pharmaceutical Services, Inc. (NYSE:WST) Given Average Rating of "Buy" by Analysts - MarketBeat
Neo Ivy Capital Management Makes New Investment in West Pharmaceutical Services, Inc. $WST - MarketBeat
Aug Closing: Will West Pharmaceutical Services Inc outperform small cap indexesMarket Rally & Scalable Portfolio Growth Ideas - baoquankhu1.vn
West Pharma climbs 0.62% following robust Q4 results and GLP-1 momentum, securing the 501st spot with $260M in trading volume as analysts highlight a 25% price premium - Bitget
S&P 500 Stock Analysis: Amazon's Potential vs. Akamai & West Pharma ConcernsNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform
What is Zacks Research's Forecast for WST Q1 Earnings? - MarketBeat
Wearable Injectors Market Set to Witness Rapid Growth Through - openPR.com
West Pharmaceutical's Long-Term Growth Intact, but Margin Expansion Less Uncertain - Morningstar
William Blair Investment Management LLC Trims Stock Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services, Inc. $WST Shares Sold by American Century Companies Inc. - MarketBeat
Transitioning your drug from a vial to combination product - Fierce Biotech
West Pharmaceutical Services, Inc. Announces Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
West Pharmaceutical (WST) SVP granted 1,285 RSUs and 3,057 options - Stock Titan
West Pharmaceutical (NYSE: WST) CEO granted new RSUs and stock options - Stock Titan
WEST PHARMACEUTICAL (WST) HR chief granted RSUs and stock options - Stock Titan
West Pharmaceutical SVP granted RSUs and options | WST SEC FilingForm 4 - Stock Titan
West Pharmaceutical (NYSE: WST) CFO awarded new RSUs and stock options - Stock Titan
West Pharmaceutical (WST) SVP awarded restricted stock units and options - Stock Titan
Finanzdaten der West Pharmaceutical Services Inc-Aktie (WST)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.09%
0.01%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):